Hint mode is switched on Switch off
Cbonds API
Integrate prices, fundamentals and corporate actions into your workflow

Get Global Stock Data via API

  • Prices & history
  • Fundamentals
  • Dividends & corporate actions

Guangzhou Kingmed Diagnostics Group, ordinary share
603882, CNE100002VW1

FIND, SAVE & TRACK INVESTMENTS WITH CBONDS WATCHLIST

With Cbonds Watchlist you can always stay updated on your investments to make conscious decisions!

Watchlist
You need to request access
Add a stock to WL
Choose all Reset all
Save Close
Guangzhou Kingmed Diagnostics Group, сountry — China
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

Try in 7-days Trial access

  • Get full online access to the database
  • Use our powerful bond screener
  • Track bond prices from 400+ sources
  • Smart Portfolio Monitoring
Unlock Data
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Dividends

Issuer

Profile
Guangzhou Kingmed Diagnostics Group Co Ltd is a China-based company principally engaged in the medical testing and pathological diagnosis businesses. The Company's main business includes the provision of physical and chemical mass spectrometry, genome testing, pathological ...
Guangzhou Kingmed Diagnostics Group Co Ltd is a China-based company principally engaged in the medical testing and pathological diagnosis businesses. The Company's main business includes the provision of physical and chemical mass spectrometry, genome testing, pathological diagnosis, biochemical luminescence testing, immunological testing and other comprehensive testing services to various medical institutions.
Show more Hide

Indicators

News

All organization news

Holders

Related Stock indices

  • SSE Composite
    3,864.28
    Value
    15/09/2026
    Date

Industry Leaders

Registration is required to get access.